Merck
MRK
#55
Rank
A$395.51 B
Marketcap
A$158.35
Share price
1.78%
Change (1 day)
1.32%
Change (1 year)

EPS for Merck (MRK)

EPS in 2025 (TTM): A$11.82

According to Merck's latest financial reports the company's current EPS (TTM) is A$10.90. In 2024 the company made an earnings per share (EPS) of A$9.71 an increase over its 2023 EPS that were of A$0.22.

EPS history for Merck from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A$11.8221.79%
2024A$9.714308.46%
2023A$0.22-97.32%
2022A$8.2310.92%
2021A$7.4284.68%
2020A$4.02-27.2%
2019A$5.5263.44%
2018A$3.38151.11%
2017A$1.34-54.58%
2016A$2.9630.21%
2015A$2.27-61.99%
2014A$5.98180.51%
2013A$2.13-31.82%
2012A$3.136.62%
2011A$2.93

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$14.99 37.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$10.57-3.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$2.47-77.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$11.57 6.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$29.46 170.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$18.71 71.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$5.32-51.20%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
A$4.26-60.89%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$5.16-52.65%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$0.90-91.70%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel